Expanded Access Programs (EAPs) are used to provide controlled and compliant access to investigational drugs for patients outside of the clinical trial setting. Many Sponsors choose to offer EAPs altruistically, as a critical treatment pathway [...]

Selecting the right CRO is crucial for biotech companies, as it can significantly impact the success of clinical trials and, ultimately, the development of new therapies. There are key reasons why value-added services are important [...]